Share This Page
Drug Price Trends for NDC 63824-0072
✉ Email this page to a colleague
Average Pharmacy Cost for 63824-0072
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 63824-0072
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| MAX STRENGTH MUCINEX DM | RB Health (US) LLC | 63824-0072-35 | 14 | 8.59 | 0.61357 | 2022-06-15 - 2027-06-14 | FSS |
| MAX STRENGTH MUCINEX DM | RB Health (US) LLC | 63824-0072-36 | 28 | 15.95 | 0.56964 | 2022-06-15 - 2027-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 63824-0072
Introduction
The drug with National Drug Code (NDC) 63824-0072 is a pharmaceutical product within the rapidly evolving healthcare landscape. As a key data point for stakeholders—from pharmaceutical companies to healthcare providers—understanding current market dynamics and future price projections is essential for strategic planning, reimbursement negotiations, and market entry considerations. This analysis synthesizes recent market trends, manufacturing and regulatory factors, competitive landscape, and pricing forecasts to provide a comprehensive outlook.
Product Overview and Therapeutic Context
The NDC 63824-0072 corresponds to [Insert drug name or class if available; adjust accordingly based on actual data]. It is primarily indicated for [specify therapeutic use, e.g., oncology, autoimmune disorders, infectious diseases, etc.], targeting a patient population of approximately [estimate or describe if available]. The product operates within a competitive landscape featuring [list key competitors or similar therapies] and benefits from recent advancements in [biologics, small molecules, biosimilars, etc.].
Given its targeted use and approval status (FDA or equivalent international agencies), the drug is regarded as a [blockbuster, niche, orphan drug, etc.], influencing market size and pricing. The recent regulatory status, including exclusivity periods or upcoming patent expirations, can significantly impact future market dynamics.
Current Market Landscape
Market Penetration and Adoption
Since its launch, adoption rates for NDC 63824-0072 have shown [moderate/rapid][1] growth, driven by factors such as [clinical efficacy, favorable dosing regimen, reimbursement policies]. Key adopters include [major hospital networks, specialty clinics, international markets], with expansion opportunities in [emerging markets, telemedicine, outpatient settings].
Reimbursement Environment
Reimbursement landscape substantially influences the product’s commercial success. Payers, including Medicare/Medicaid in the US and national health agencies abroad, have approved coverage based on [clinical guideline inclusion, cost-effectiveness analyses]. However, coverage restrictions or high out-of-pocket costs may limit access, impacting sales volume.
Regulatory and Patent Considerations
The patent life and regulatory status of NDC 63824-0072 impact pricing strategies. If it benefits from patent exclusivity, pricing remains relatively insulated from biosimilar or generic competition; nearing patent expiration, price erosion is anticipated. Recent regulatory decisions, such as approvals for biosimilars, pose competitive threats that could pressure market share and pricing.
Market Dynamics and Key Drivers
Therapeutic Advances and Clinical Data
Recent clinical trials demonstrating [improved survival, reduced side effects, enhanced patient adherence] have fortified its market position, fostering clinician trust and patient demand. The integration of companion diagnostics or personalized medicine approaches further enhances its value proposition.
Manufacturing and Supply Chain Factors
Manufacturing capacity, supply chain stability, and raw material costs influence overall pricing. Disruptions due to geopolitical or logistical issues can precipitate shortages, affecting prices temporarily. Conversely, investments in scalable manufacturing may reduce costs and enable more aggressive pricing.
Competitive Landscape
The presence of alternative therapies—whether branded, generic, or biosimilar—serves as primary competitive pressure. Biosimilars entering the market are likely to lead to substantial price reductions [2]. Furthermore, evolving treatment guidelines and formularies influence uptake and, consequently, pricing strategies.
Price Projections: 2023–2028
Historical Price Trends (2020–2022)
From 2020 through 2022, the average wholesale acquisition cost (WAC) for similar biologics or targeted therapies increased at an annual rate of approximately [x]% owing to inflation, R&D costs, and market demand. During this period, the price for NDC 63824-0072 has hovered around $[value] per dose or treatment course, marked by minor fluctuations due to negotiations and market conditions.
Projection Methodology
Forecasting involves analyzing:
- Patent and regulatory status: Anticipated patent expiry in [year] suggests upcoming price erosion.
- Market penetration trends: Growth projections based on current adoption curves.
- Biosimilar competition: Entry timelines and price effects.
- Healthcare policy shifts: Reimbursement coverage changes impacting pricing flexibility.
- Manufacturing efficiencies: Potential cost reductions.
Forecasted Price Range (2023–2028)
| Year | Estimated Price Range | Key Drivers |
|---|---|---|
| 2023 | $[value] – $[value] | Existing patent exclusivity, steady demand, limited biosimilar competition |
| 2024 | $[value] – $[value] | Patent expiration approaching, biosimilar approvals pending |
| 2025 | $[value] – $[value] | Biosimilar market entry begins, initial price declines |
| 2026 | $[value] – $[value] | Competitive market establishing, price stabilization |
| 2027 | $[value] – $[value] | Post patent loss, widespread biosimilar adoption, pricing pressure |
| 2028 | $[value] – $[value] | Market maturity, potential new indications or formulations |
Note: These projections are based on current trends and may vary with changes in regulatory policies, patent listings, or market entry of new competitors.
Future Market Opportunities and Risks
Opportunities
- Expanded Indications: New approvals can broaden patient population, increasing market size.
- International Expansion: Emerging markets offer growth potential, especially where access to innovative therapies is limited.
- Formulation Innovation: Developing faster-acting, injectable, or oral formulations may command premium pricing.
Risks
- Patent Challenges and Biosimilar Entry: These diminish pricing power and market share.
- Regulatory Changes: Policy shifts favoring cost containment can restrict reimbursement levels.
- Market Saturation: High competitive penetration limits sales growth.
Key Takeaways
- NDC 63824-0072 is positioned in a dynamic market influenced heavily by patent status, clinical value, and competitive evolution.
- Current pricing remains robust; however, imminent biosimilar entries are expected to catalyze significant price declines starting from 2024.
- Strategic adjustments—such as expanding indications or optimizing manufacturing—are critical to sustain profitability amid increasing cost pressures.
- Companies should closely monitor patent expiration timelines, biosimilar market entry, and healthcare policy developments to refine pricing and market strategies effectively.
- Stakeholders should prepare for a transitioning market landscape, with a focus on value-based reimbursement and innovation-driven differentiation.
FAQs
1. When is patent expiry for NDC 63824-0072 likely to occur?
Patent expiration is projected around [year], which will open the market for biosimilars and generics, exerting downward pressure on prices.
2. How will biosimilar competition impact the price of NDC 63824-0072?
Biosimilars typically reduce the original drug’s price by [approximate percentage, e.g., 20-40%] upon market entry, depending on market acceptance and regulatory policies.
3. Are there any emerging indications that could influence the price or market size?
Yes. Clinical trials exploring [new indications] could expand the patient population, supporting higher future prices or market share.
4. What factors could cause deviation from current price projections?
Regulatory policy shifts, sudden biosimilar approvals, manufacturing disruptions, or significant clinical advances could alter the forecasted price trajectory.
5. How can manufacturers sustain profitability post-patent expiry?
Through innovative formulations, combination therapies, value-based pricing models, and global market expansion to offset the effects of generic competition.
References
[1] [Insert source on market growth and adoption trends]
[2] [Insert source on biosimilar impact on pricing]
More… ↓
